1. Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature
- Author
-
Himanshu Pruthi, Valliappan Muthu, Harish Bhujade, Arun Sharma, Abhiman Baloji, Rao G Ratnakara, Amanjit Bal, Harkant Singh, Manavjit Singh Sandhu, Sunder Negi, Arunaloke Chakrabarti, and Manphool Singhal
- Subjects
Male ,SARS-CoV-2 ,Veterinary (miscellaneous) ,Short Communication ,Pulmonary aspergillosis ,Angiography ,COVID-19 ,Pulmonary Artery ,Applied Microbiology and Biotechnology ,Microbiology ,Mycotic aneurysm ,Fungal pneumonia ,Mucorales ,Humans ,Mucormycosis ,Female ,Agronomy and Crop Science ,Aneurysm, False ,Rhizopus - Abstract
Literature on COVID-19-associated pulmonary mucormycosis (CAPM) is sparse. Pulmonary artery pseudoaneurysm (PAP) is an uncommon complication of pulmonary mucormycosis (PM), and rarely reported in CAPM. Herein, we report five cases of CAPM with PAP managed at our center and perform a systematic review of the literature. We diagnosed PM in those with clinico-radiological suspicion and confirmed it by microbiology or histopathology. We encountered five cases of CAPM with PAP (size ranged from 1 × 0.8 cm to ~ 4.9 × 4.8 cm). All subjects had diabetes and were aged 55–62 years (75% men). In two cases, COVID-19 and mucormycosis were diagnosed simultaneously, while in three others, COVID-19 preceded PM. One subject who underwent surgery survived, while all others died (80% mortality). From our systematic review, we identified one additional case of CAPM with PAP in a transplant recipient. CAPM with PAP is rare with high mortality. Early diagnosis and multimodality management are imperative to improve outcomes. Supplementary Information The online version contains supplementary material available at 10.1007/s11046-021-00610-9.
- Published
- 2021